Co-Diagnostics (HAM:C970) Inventories, Raw Materials & Components: €0.42 Mil (As of Mar. 2026)


HAM:C970 Co-Diagnostics Inc HAM:C970
60 GF Score
Price €5.55
GF Value €3.88
! 6 Warning Signs
View Full Analysis

What is Co-Diagnostics Inventories, Raw Materials & Components?

Co-Diagnostics HAM:C970 60 Inventories, Raw Materials & Components is €0.42 Mil as of Mar. 2026. GuruFocus rates HAM:C970 with a GF Score™ of 60/100 and a GF Value™ of €3.88. The stock has 6 warning signs investors should review.

Co-Diagnostics's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €0.42 Mil.

Co-Diagnostics's quarterly raw materials declined from Sep. 2025 (€0.41 Mil) to Dec. 2025 (€0.41 Mil) but then increased from Dec. 2025 (€0.41 Mil) to Mar. 2026 (€0.42 Mil).

Co-Diagnostics's annual raw materials declined from Dec. 2023 (€0.88 Mil) to Dec. 2024 (€0.48 Mil) and declined from Dec. 2024 (€0.48 Mil) to Dec. 2025 (€0.41 Mil).

Co-Diagnostics Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Co-Diagnostics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Co-Diagnostics Inventories, Raw Materials & Components Chart

Co-Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 3.76 0.88 0.48 0.41

Co-Diagnostics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.42 0.41 0.41 0.42
HAM:C970
60GF Score
Co-Diagnostics Inc HAM:C970
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Co-Diagnostics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €0.42 Mil mean?
Co-Diagnostics (HAM:C970) has a Inventories, Raw Materials & Components of €0.42 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Co-Diagnostics and its competitors.
Is Co-Diagnostics' Inventories, Raw Materials & Components too high?
Co-Diagnostics' current Inventories, Raw Materials & Components is €0.42 Mil. Overall, Co-Diagnostics has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Co-Diagnostics' Inventories, Raw Materials & Components compare to CTSO and NMTC?
Co-Diagnostics' Inventories, Raw Materials & Components of €0.42 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Co-Diagnostics and its competitors. Co-Diagnostics's current Inventories, Raw Materials & Components is €0.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Co-Diagnostics stock overvalued right now?
Co-Diagnostics (HAM:C970) has a current Inventories, Raw Materials & Components of €0.42 Mil. The stock's GF Value™ is €3.88, compared to a current price of €5.55 — trading 43% above its estimated fair value. The current Inventories, Raw Materials & Components is €0.42 Mil. Co-Diagnostics' overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Co-Diagnostics (HAM:C970), the current Inventories, Raw Materials & Components is €0.42 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Co-Diagnostics (HAM:C970) Overvalued in 2026?

Based on GuruFocus' analysis, Co-Diagnostics stock appears to be overvalued. The current stock price of €5.55 is trading 43% above its estimated GF Value™ of €3.88.

Key valuation signals for HAM:C970:

  • Inventories, Raw Materials & Components: €0.42 Mil
  • GF Value™: €3.88 vs. price of €5.55 (43% above fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the HAM:C970 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Co-Diagnostics Business Description

Other Exchanges CODX:USA0A50:UK
Address 2401 S. Foothill Drive, Suite D, Salt Lake City, UT, USA, 84109
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
60GF Score

Get the complete analysis for HAM:C970

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.55
Price
€3.88
GF Value